Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Ischemia | 17 | 2024 | 2139 | 3.090 |
Why?
|
Cardiopulmonary Bypass | 6 | 2024 | 1097 | 1.480 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 3 | 2024 | 317 | 0.970 |
Why?
|
Swine | 18 | 2024 | 5997 | 0.840 |
Why?
|
Heart Arrest, Induced | 3 | 2024 | 361 | 0.820 |
Why?
|
Arterioles | 3 | 2024 | 252 | 0.820 |
Why?
|
Coronary Circulation | 7 | 2024 | 1617 | 0.740 |
Why?
|
Vasoconstriction | 3 | 2024 | 593 | 0.740 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2024 | 484 | 0.720 |
Why?
|
Myocardium | 14 | 2024 | 4790 | 0.670 |
Why?
|
Coronary Vessels | 4 | 2024 | 3124 | 0.660 |
Why?
|
Receptors, Serotonin | 2 | 2024 | 211 | 0.620 |
Why?
|
Disease Models, Animal | 17 | 2024 | 18354 | 0.560 |
Why?
|
Cardiac Surgical Procedures | 4 | 2024 | 3683 | 0.470 |
Why?
|
Hypertension | 3 | 2024 | 8617 | 0.470 |
Why?
|
Perfusion | 3 | 2023 | 1402 | 0.450 |
Why?
|
Neovascularization, Physiologic | 3 | 2024 | 1371 | 0.390 |
Why?
|
Fibrosis | 3 | 2024 | 2080 | 0.290 |
Why?
|
Ischemic Preconditioning, Myocardial | 2 | 2024 | 69 | 0.290 |
Why?
|
Serotonin | 2 | 2024 | 1043 | 0.270 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5176 | 0.240 |
Why?
|
Phorbols | 1 | 2024 | 44 | 0.230 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5892 | 0.230 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2023 | 64 | 0.230 |
Why?
|
Thromboxane A2 | 1 | 2023 | 87 | 0.220 |
Why?
|
Calpain | 2 | 2023 | 146 | 0.220 |
Why?
|
Animals | 20 | 2024 | 169335 | 0.210 |
Why?
|
Vasopressins | 1 | 2024 | 358 | 0.210 |
Why?
|
Angiostatins | 1 | 2022 | 64 | 0.210 |
Why?
|
Phenylephrine | 1 | 2022 | 293 | 0.190 |
Why?
|
Microvessels | 2 | 2024 | 586 | 0.190 |
Why?
|
Cardiotonic Agents | 1 | 2024 | 544 | 0.180 |
Why?
|
Microcirculation | 2 | 2024 | 1281 | 0.180 |
Why?
|
Symporters | 1 | 2023 | 363 | 0.180 |
Why?
|
Glycoproteins | 2 | 2020 | 2202 | 0.180 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2022 | 706 | 0.170 |
Why?
|
Ischemic Attack, Transient | 1 | 2023 | 877 | 0.150 |
Why?
|
Interleukin-10 | 1 | 2022 | 1183 | 0.140 |
Why?
|
Metformin | 1 | 2024 | 909 | 0.130 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2016 | 185 | 0.130 |
Why?
|
Proteomics | 3 | 2024 | 3914 | 0.130 |
Why?
|
Protein Kinases | 1 | 2022 | 1611 | 0.130 |
Why?
|
Vasodilation | 3 | 2024 | 967 | 0.120 |
Why?
|
Antioxidants | 1 | 2022 | 1673 | 0.120 |
Why?
|
Collagen | 2 | 2020 | 2646 | 0.120 |
Why?
|
NF-kappa B | 1 | 2022 | 2492 | 0.110 |
Why?
|
Endothelium, Vascular | 2 | 2024 | 4428 | 0.110 |
Why?
|
Ventricular Remodeling | 1 | 2020 | 1282 | 0.100 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11521 | 0.100 |
Why?
|
Interleukin-6 | 1 | 2022 | 3232 | 0.100 |
Why?
|
Mesenchymal Stem Cells | 1 | 2023 | 1672 | 0.100 |
Why?
|
Ventricular Function, Right | 1 | 2016 | 628 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2023 | 1936 | 0.090 |
Why?
|
Oxidative Stress | 2 | 2023 | 3139 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4356 | 0.090 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2016 | 644 | 0.090 |
Why?
|
Coronary Artery Disease | 3 | 2024 | 6569 | 0.080 |
Why?
|
Insulin | 1 | 2024 | 6610 | 0.080 |
Why?
|
Pilot Projects | 1 | 2023 | 8748 | 0.080 |
Why?
|
Humans | 14 | 2024 | 768970 | 0.070 |
Why?
|
Chronic Disease | 4 | 2024 | 9384 | 0.070 |
Why?
|
Substance-Related Disorders | 1 | 2023 | 4423 | 0.070 |
Why?
|
Signal Transduction | 3 | 2024 | 23653 | 0.070 |
Why?
|
Myristates | 1 | 2024 | 12 | 0.060 |
Why?
|
Receptors, Vasopressin | 1 | 2024 | 106 | 0.060 |
Why?
|
Mitochondria | 1 | 2018 | 3682 | 0.060 |
Why?
|
Small-Conductance Calcium-Activated Potassium Channels | 1 | 2024 | 38 | 0.060 |
Why?
|
Protein Carbonylation | 1 | 2023 | 27 | 0.060 |
Why?
|
Cardiomyopathies | 1 | 2016 | 2057 | 0.060 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2023 | 72 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 4978 | 0.050 |
Why?
|
Endostatins | 1 | 2023 | 168 | 0.050 |
Why?
|
Sus scrofa | 1 | 2024 | 430 | 0.050 |
Why?
|
Acetates | 1 | 2024 | 317 | 0.050 |
Why?
|
Stroke Volume | 1 | 2016 | 5622 | 0.050 |
Why?
|
Oxidative Phosphorylation | 1 | 2024 | 501 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9756 | 0.050 |
Why?
|
Hypoglycemic Agents | 2 | 2024 | 3110 | 0.050 |
Why?
|
Injections, Intravenous | 1 | 2023 | 1379 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2018 | 22296 | 0.040 |
Why?
|
Sex Factors | 2 | 2024 | 10633 | 0.040 |
Why?
|
NAD | 1 | 2024 | 618 | 0.040 |
Why?
|
STAT Transcription Factors | 1 | 2020 | 189 | 0.040 |
Why?
|
Male | 9 | 2024 | 365203 | 0.040 |
Why?
|
Glycolysis | 1 | 2023 | 838 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2023 | 2298 | 0.040 |
Why?
|
Aged | 5 | 2024 | 171786 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 980 | 0.040 |
Why?
|
Chemokine CCL2 | 1 | 2020 | 606 | 0.040 |
Why?
|
Female | 8 | 2024 | 397515 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2020 | 560 | 0.030 |
Why?
|
Middle Aged | 5 | 2024 | 223737 | 0.030 |
Why?
|
Fatty Acids | 1 | 2023 | 1812 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2023 | 2149 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2024 | 3433 | 0.030 |
Why?
|
Ischemia | 1 | 2023 | 1900 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2023 | 2194 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2884 | 0.030 |
Why?
|
Hemodynamics | 1 | 2024 | 4199 | 0.030 |
Why?
|
Proteome | 1 | 2024 | 1891 | 0.030 |
Why?
|
Hypercholesterolemia | 1 | 2020 | 1145 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2023 | 3518 | 0.030 |
Why?
|
Glucose | 1 | 2023 | 4352 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3592 | 0.020 |
Why?
|
Risk Factors | 3 | 2023 | 74976 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1890 | 0.020 |
Why?
|
Rats | 1 | 2023 | 23786 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 7081 | 0.020 |
Why?
|
Inflammation | 1 | 2023 | 10868 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9527 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7453 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5707 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15471 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2023 | 65480 | 0.010 |
Why?
|
Mice | 1 | 2023 | 82072 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 30046 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39394 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 81903 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 41808 | 0.010 |
Why?
|
Concepts
(119)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_